IKang: Endgame Approaching, But Fair Price Is Distant
iKang Healthcare Group (ADR) (KANG US) 's December quarter results provide updated benchmarks for evaluating Yunfeng and Alibaba's US$20/ADS offer...
471 Views
EV71 Prices in Line: Now About That Bid
Sinovac's vaccine for EV71 (Hand Foot and Mouth disease) launched in China's private market this summer after disruptions caused by the infamous...
282 Views
Never Leave An Opening: Exhibit Two
US-listed Chinese vaccine manufacturer Sinovac Biotech (SVA:US) is the subject of a bidding was between two groups: SVA's Chairman in conjunction...
232 Views